{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33193799", "DateRevised": {"Year": "2020", "Month": "11", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "28"}], "Language": ["eng"], "ELocationID": ["8257817", "10.1155/2020/8257817"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "A Review of Malaysian Herbal Plants and Their Active Constituents with Potential Therapeutic Applications in Sepsis.", "Pagination": {"StartPage": "8257817", "MedlinePgn": "8257817"}, "Abstract": {"AbstractText": ["Sepsis refers to organ failure due to uncontrolled body immune responses towards infection. The systemic inflammatory response triggered by pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS) from Gram-negative bacteria, is accompanied by the release of various proinflammatory mediators that can lead to organ damage. The progression to septic shock is even more life-threatening due to hypotension. Thus, sepsis is a leading cause of death and morbidity globally. However, current therapies are mainly symptomatic treatment and rely on the use of antibiotics. The lack of a specific treatment demands exploration of new drugs. Malaysian herbal plants have a long history of usage for medicinal purposes. A total of 64 Malaysian plants commonly used in the herbal industry have been published in Malaysian Herbal Monograph 2015 and Globinmed website (http://www.globinmed.com/). An extensive bibliographic search in databases such as PubMed, ScienceDirect, and Scopus revealed that seven of these plants have antisepsis properties, as evidenced by the therapeutic effect of their extracts or isolated compounds against sepsis-associated inflammatory responses or conditions in <i>in vitro</i> or/and <i>in vivo</i> studies. These include <i>Andrographis paniculata</i>, <i>Zingiber officinale</i>, <i>Curcuma longa</i>, <i>Piper nigrum</i>, <i>Syzygium aromaticum</i>, <i>Momordica charantia</i>, and <i>Centella asiatica</i>. Among these, <i>Z. officinale</i> is the most widely studied plant and seems to have the highest potential for future therapeutic applications in sepsis. Although both extracts as well as active constituents from these herbal plants have demonstrated potential antisepsis activity, the activity might be primarily contributed by the active constituent(s) from each of these plants, which are andrographolide (<i>A. paniculata</i>), 6-gingerol and zingerone (<i>Z. officinale</i>), curcumin (<i>C. longa</i>), piperine and pellitorine (<i>P. nigrum</i>), biflorin (<i>S. aromaticum</i>), and asiaticoside, asiatic acid, and madecassoside (<i>C. asiatica</i>). These active constituents have shown great antisepsis effects, and further investigations into their clinical therapeutic potential may be worthwhile."], "CopyrightInformation": "Copyright \u00a9 2020 Kong Yen Liew et al."}, "AuthorList": [{"Identifier": ["0000-0002-5443-5507"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia."}], "LastName": "Liew", "ForeName": "Kong Yen", "Initials": "KY"}, {"Identifier": ["0000-0003-3811-0320"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia."}], "LastName": "Hafiz", "ForeName": "Md Faizul", "Initials": "MF"}, {"Identifier": ["0000-0002-2390-6820"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia."}], "LastName": "Chong", "ForeName": "Yi Joong", "Initials": "YJ"}, {"Identifier": ["0000-0001-7066-8119"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia."}], "LastName": "Harith", "ForeName": "Hanis Hazeera", "Initials": "HH"}, {"Identifier": ["0000-0003-2936-6156"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia."}], "LastName": "Israf", "ForeName": "Daud Ahmad", "Initials": "DA"}, {"Identifier": ["0000-0002-9734-0372"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia."}], "LastName": "Tham", "ForeName": "Chau Ling", "Initials": "CL"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that there are no conflicts of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Reinhart K., Daniels R., Kissoon N., Machado F. R., Schachter R. D., Finfer S. Recognizing sepsis as a global health priority\u2014a WHO resolution. New England Journal of Medicine. 2017;377(5):414\u2013417. doi: 10.1056/nejmp1707170.", "ArticleIdList": ["10.1056/nejmp1707170", "28658587"]}, {"Citation": "Rhodes A., Evans L. E., Alhazzani W., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine. 2017;43(3):304\u2013377.", "ArticleIdList": ["28101605"]}, {"Citation": "Ward P. A. New approaches to the study of sepsis. EMBO Molecular Medicine. 2012;4(12):1234\u20131243. doi: 10.1002/emmm.201201375.", "ArticleIdList": ["10.1002/emmm.201201375", "PMC3531600", "23208733"]}, {"Citation": "Singer M., Deutschman C. S., Seymour C. W., et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315(8):801\u2013810. doi: 10.1001/jama.2016.0287.", "ArticleIdList": ["10.1001/jama.2016.0287", "PMC4968574", "26903338"]}, {"Citation": "Levy X.-h., Yin Y. J., Zhang J. X. Sepsis and immune response. World Journal of Emergency Medicine. 2011;2(2):p. 88. doi: 10.5847/wjem.j.1920-8642.2011.02.002.", "ArticleIdList": ["10.5847/wjem.j.1920-8642.2011.02.002", "PMC4129694", "25214990"]}, {"Citation": "Mogensen T. H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clinical Microbiology Reviews. 2009;22(2):240\u2013273. doi: 10.1128/cmr.00046-08.", "ArticleIdList": ["10.1128/cmr.00046-08", "PMC2668232", "19366914"]}, {"Citation": "Schulte W., Bernhagen J., Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2014an updated view. Mediators of Inflammation. 2013;2013 doi: 10.1155/2013/165974.", "ArticleIdList": ["10.1155/2013/165974", "PMC3703895", "23853427"]}, {"Citation": "Dugani S., Veillard J., Kissoon N. Reducing the global burden of sepsis. Canadian Medical Association Journal. 2017;189(1):E2\u2013E3. doi: 10.1503/cmaj.171008.", "ArticleIdList": ["10.1503/cmaj.171008", "PMC5224944", "28246252"]}, {"Citation": "Fleischmann C., Scherag A., Adhikari N. K. J., et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. American Journal of Respiratory and Critical Care Medicine. 2016;193(3):259\u2013272. doi: 10.1164/rccm.201504-0781oc.", "ArticleIdList": ["10.1164/rccm.201504-0781oc", "26414292"]}, {"Citation": "Dantes R. B., Epstein L. Combatting sepsis: a public health perspective. Clinical Infectious Diseases. 2018;67(8):1300\u20131302. doi: 10.1093/cid/ciy342.", "ArticleIdList": ["10.1093/cid/ciy342", "PMC6557150", "29846544"]}, {"Citation": "Rhee C., Dantes R., Epstein L., et al. and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014. Jama. 2017;318(13):1241\u20131249. doi: 10.1001/jama.2017.13836.", "ArticleIdList": ["10.1001/jama.2017.13836", "PMC5710396", "28903154"]}, {"Citation": "Martin J. M., Tai L., Tan C., Ahmad S., Lim C. Malaysian registry of intensive care report 2017. November 2019.   http://www.mric.org.my/Content/Document/MRICPublications/mricreport2010.pdf."}, {"Citation": "Hashairi F., Hasan H., Azlan K., Deris Z. Z. An eight-year review of blood culture and susceptibility among sepsis cases in an emergency department in Northeastern Malaysia. Tropical Biomedicine. 2011;28(3):599\u2013605.", "ArticleIdList": ["22433889"]}, {"Citation": "Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420(6917):885\u2013891. doi: 10.1038/nature01326.", "ArticleIdList": ["10.1038/nature01326", "12490963"]}, {"Citation": "Wiersinga W. J., Leopold S. J., Cranendonk D. R., van der Poll T. Host innate immune responses to sepsis. Virulence. 2014;5(1):36\u201344. doi: 10.4161/viru.25436.", "ArticleIdList": ["10.4161/viru.25436", "PMC3916381", "23774844"]}, {"Citation": "Russell J. A., Boyd J., Nakada T., Thair S., Walley K. R. Molecular mechanisms of sepsis. Sepsis - Pro-Inflammatory and Anti-Inflammatory Responses. 2011;17:48\u201385. doi: 10.1159/000324009.", "ArticleIdList": ["10.1159/000324009", "21659747"]}, {"Citation": "Gyawali B., Ramakrishna K., Dhamoon A. S. Sepsis: the evolution in definition, pathophysiology, and management. SAGE Open Medicine. 2019;7 doi: 10.1177/2050312119835043.", "ArticleIdList": ["10.1177/2050312119835043", "PMC6429642", "30915218"]}, {"Citation": "Rittirsch D., Flierl M. A., Ward P. A. Harmful molecular mechanisms in sepsis. Nature Reviews Immunology. 2008;8(10):776\u2013787. doi: 10.1038/nri2402.", "ArticleIdList": ["10.1038/nri2402", "PMC2786961", "18802444"]}, {"Citation": "Huang W., Tang Y., Li L. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine. 2010;51(2):119\u2013126. doi: 10.1016/j.cyto.2010.02.021.", "ArticleIdList": ["10.1016/j.cyto.2010.02.021", "20347329"]}, {"Citation": "Fink M. P. Prostaglandins and sepsis: still a fascinating topic despite almost 40 years of research. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2001;281(3):L534\u2013L536. doi: 10.1152/ajplung.2001.281.3.l534.", "ArticleIdList": ["10.1152/ajplung.2001.281.3.l534", "11504677"]}, {"Citation": "Aronoff D. M. Cyclooxygenase inhibition in sepsis: is there life after death? Mediators of Inflammation. 2012;2012 doi: 10.1155/2012/696897.", "ArticleIdList": ["10.1155/2012/696897", "PMC3361325", "22665954"]}, {"Citation": "Wang L., Wu J., Guo X., Huang X., Huang Q. RAGE plays a role in LPS-induced NF-\u03baB activation and endothelial hyperpermeability. Sensors. 2017;17(4):p. 722. doi: 10.3390/s17040722.", "ArticleIdList": ["10.3390/s17040722", "PMC5421682", "28358333"]}, {"Citation": "Peters K., Unger R. E., Brunner J., Kirkpatrick C. J. Molecular basis of endothelial dysfunction in sepsis. Cardiovascular Research. 2003;60(1):49\u201357. doi: 10.1016/s0008-6363(03)00397-3.", "ArticleIdList": ["10.1016/s0008-6363(03)00397-3", "14522406"]}, {"Citation": "Dellinger R. P., Carlet J. M., Masur H., et al. Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Medicine. 2004;30(4):536\u2013555. doi: 10.1007/s00134-004-2210-z.", "ArticleIdList": ["10.1007/s00134-004-2210-z", "14997291"]}, {"Citation": "Zimmerman R. P., Levy M. M., Carlet J. M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Medicine. 2008;34(1):17\u201360. doi: 10.1007/s00134-007-0934-2.", "ArticleIdList": ["10.1007/s00134-007-0934-2", "PMC2249616", "18058085"]}, {"Citation": "Dhainaut S. S., Dellinger R. P., Levy M. M, et al. International guidelines for management of severe sepsis and septic shock. Critical Care Medicine. 2013;41(2):580\u2013637.", "ArticleIdList": ["23353941"]}, {"Citation": "Levy M. M., Evans L. E., Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Medicine. 2018;44(6):925\u2013928. doi: 10.1007/s00134-018-5085-0.", "ArticleIdList": ["10.1007/s00134-018-5085-0", "29675566"]}, {"Citation": "Herr\u00e1n-Monge R., Muriel-Bomb\u00edn A., Garc\u00eda-Garc\u00eda M. M., et al. Mortality reduction and long-term compliance with surviving sepsis campaign. Shock. 2016;45(6):598\u2013606. doi: 10.1097/shk.0000000000000555.", "ArticleIdList": ["10.1097/shk.0000000000000555", "27186683"]}, {"Citation": "Fern\u00e1ndez Calavia E., Wunderink R., Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA: The Journal of the American Medical Association. 1995;273(12):934\u2013941. doi: 10.1001/jama.1995.03520360048038.", "ArticleIdList": ["10.1001/jama.1995.03520360048038", "7884952"]}, {"Citation": "Abraham E., Glauser M. P., Butler T, et al. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 study group. JAMA: The Journal of the American Medical Association. 1997;277(19):1531\u20131538. doi: 10.1001/jama.277.19.1531.", "ArticleIdList": ["10.1001/jama.277.19.1531", "9153367"]}, {"Citation": "Fisher C. J., Dhainaut J. F., Opal S. M, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. phase III rhIL-1ra sepsis syndrome study group. JAMA: The Journal of the American Medical Association. 1994;271(23):1836\u20131843. doi: 10.1001/jama.271.23.1836.", "ArticleIdList": ["10.1001/jama.271.23.1836", "8196140"]}, {"Citation": "Freeman B. D., Zehnbauer B. A., Buchman T. G. A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis. Shock. 2003;20(1):5\u20139. doi: 10.1097/01.shk.0000068327.26733.10.", "ArticleIdList": ["10.1097/01.shk.0000068327.26733.10", "12813361"]}, {"Citation": "L\u00f3pez A., Lorente J. A., Steingrub J., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Critical Care Medicine. 2004;32(1):21\u201330. doi: 10.1097/01.ccm.0000105581.01815.c6.", "ArticleIdList": ["10.1097/01.ccm.0000105581.01815.c6", "14707556"]}, {"Citation": "Takala A. M. Drotrecogin alfa (activated): the first FDA-approved treatment for severe sepsis. Baylor University Medical Center Proceedings. 2002;15(2):224\u2013227. doi: 10.1080/08998280.2002.11927844.", "ArticleIdList": ["10.1080/08998280.2002.11927844", "PMC1276518", "16333441"]}, {"Citation": "Green R. S., Djogovic D., Howes D. Sepsis update: management of severe sepsis and septic shock in the emergency department after the withdrawal of Xigris. CJEM. 201;14(5):265\u2013266. doi: 10.2310/8000.2012.120769.", "ArticleIdList": ["10.2310/8000.2012.120769", "22967692"]}, {"Citation": "Rochwerg B., Oczkowski S. J., Siemieniuk R. A. C., et al. Corticosteroids in sepsis. Critical Care Medicine. 2018;46(9):1411\u20131420. doi: 10.1097/ccm.0000000000003262.", "ArticleIdList": ["10.1097/ccm.0000000000003262", "29979221"]}, {"Citation": "Menon K. Sepsis treatment options are often lacking. P & T: A Peer-Reviewed Journal for Formulary Management. 2015;40(7):p. 466.", "ArticleIdList": ["PMC4495874", "26185408"]}, {"Citation": "Buras J. A., Holzmann B., Sitkovsky M. Animal models of sepsis: setting the stage. Nature Reviews Drug Discovery. 2005;4(10):854\u2013865. doi: 10.1038/nrd1854.", "ArticleIdList": ["10.1038/nrd1854", "16224456"]}, {"Citation": "Poli-de-Figueiredo L. F., Garrido A. G., Nakagawa N., Sannomiya P. Experimental models of sepsis and their clinical relevance. Shock. 2008;30(7):53\u201359. doi: 10.1097/shk.0b013e318181a343.", "ArticleIdList": ["10.1097/shk.0b013e318181a343", "18704008"]}, {"Citation": "Dejager L., Pinheiro I., Dejonckheere E., Libert C. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends in Microbiology. 2011;19(4):198\u2013208. doi: 10.1016/j.tim.2011.01.001.", "ArticleIdList": ["10.1016/j.tim.2011.01.001", "21296575"]}, {"Citation": "Su X.-Z., Miller L. H. The discovery of artemisinin and the Nobel prize in Physiology or medicine. Science China Life Sciences. 2015;58(11):1175\u20131179. doi: 10.1007/s11427-015-4948-7.", "ArticleIdList": ["10.1007/s11427-015-4948-7", "PMC4966551", "26481135"]}, {"Citation": "Kim Sooi L., Lean Keng S. Herbal medicines: Malaysian women\u2019s knowledge and practice. Evidence-Based Complementary and Alternative Medicine. 2013;2013:10. doi: 10.1155/2013/438139.438139", "ArticleIdList": ["10.1155/2013/438139", "PMC3777224", "24093047"]}, {"Citation": "Chao W.-W., Kuo Y.-H., Li W.-C., Lin B.-F. The production of nitric oxide and prostaglandin E2 in peritoneal macrophages is inhibited by Andrographis paniculata, Angelica sinensis and Morus alba ethyl acetate fractions. Journal of Ethnopharmacology. 2009;122(1):68\u201375. doi: 10.1016/j.jep.2008.11.029.", "ArticleIdList": ["10.1016/j.jep.2008.11.029", "19111919"]}, {"Citation": "Chao W. W., Kuo Y. H., Hsieh S. L., Lin B. F. Inhibitory effects of ethyl acetate extract of Andrographis paniculata on NF-\u03baB trans-activation activity and LPS-induced acute inflammation in mice. Evidence-Based Complementary and Alternative Medicine. 2011;2011:9. doi: 10.1093/ecam/nep120.254531", "ArticleIdList": ["10.1093/ecam/nep120", "PMC3096457", "19745004"]}, {"Citation": "Lee W., Ku S., Yoo H., Song K., Bae J. Andrographolide inhibits HMGB1-induced inflammatory responses in human umbilical vein endothelial cells and in murine polymicrobial sepsis. Acta Physiologica. 2014;211(1):176\u2013187. doi: 10.1111/apha.12264.", "ArticleIdList": ["10.1111/apha.12264", "24581270"]}, {"Citation": "Zhu T., Wang D. X., Zhang W, et al. Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-\u03baB. PLoS One. 2013;8(2) doi: 10.1371/journal.pone.0056407.", "ArticleIdList": ["10.1371/journal.pone.0056407", "PMC3578846", "23437127"]}, {"Citation": "Pan C.-W., Yang S.-X., Pan Z.-Z., et al. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway. Oncotarget. 2017;8(25):p. 41202. doi: 10.18632/oncotarget.17149.", "ArticleIdList": ["10.18632/oncotarget.17149", "PMC5522263", "28465482"]}, {"Citation": "Tripathi S., Bruch D., Kittur D. S. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complementary and Alternative Medicine. 2008;8(1):p. 1. doi: 10.1186/1472-6882-8-1.", "ArticleIdList": ["10.1186/1472-6882-8-1", "PMC2234390", "18173849"]}, {"Citation": "Tripathi S., Maier K. G., Bruch D., Kittur D. S. Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages. Journal of Surgical Research. 2007;138(2):209\u2013213. doi: 10.1016/j.jss.2006.07.051.", "ArticleIdList": ["10.1016/j.jss.2006.07.051", "17291534"]}, {"Citation": "Lee W., Ku S.-K., Bae J.-S. Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice. Toxicology and Applied Pharmacology. 2017;329:202\u2013211. doi: 10.1016/j.taap.2017.06.006.", "ArticleIdList": ["10.1016/j.taap.2017.06.006", "28610995"]}, {"Citation": "Min G., Ku S.-K., Lee T., Bae J.-S. Suppressive effects of zingerone on TGFBIp-mediated septic responses. Archives of Pharmacal Research. 2018;41(3):276\u2013287. doi: 10.1007/s12272-017-0919-9.", "ArticleIdList": ["10.1007/s12272-017-0919-9", "28508944"]}, {"Citation": "Choi Y. Y., Kim M. H., Hong J., Kim S. H., Yang W. M. Dried ginger (Zingiber officinalis) inhibits inflammation in a lipopolysaccharide-induced mouse model. Evidence-based Complementary and Alternative Medicine. 2013;2013 doi: 10.1155/2013/914563.", "ArticleIdList": ["10.1155/2013/914563", "PMC3712229", "23935687"]}, {"Citation": "Hong M.-K., Hu L.-L., Zhang Y.-X., et al. 6-Gingerol ameliorates sepsis-induced liver injury through the Nrf2 pathway. International Immunopharmacology. 2020;80:p. 106196. doi: 10.1016/j.intimp.2020.106196.", "ArticleIdList": ["10.1016/j.intimp.2020.106196", "31978803"]}, {"Citation": "Xie X., Sun S., Zhong W., et al. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice. International Immunopharmacology. 2014;19(1):103\u2013109. doi: 10.1016/j.intimp.2013.12.028.", "ArticleIdList": ["10.1016/j.intimp.2013.12.028", "24412620"]}, {"Citation": "Song J., Fan H.-J., Li H., Ding H., Lv Q., Hou S.-K. Zingerone ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting Toll-like receptor 4 signaling pathway. European Journal of Pharmacology. 2016;772:108\u2013114. doi: 10.1016/j.ejphar.2015.12.027.", "ArticleIdList": ["10.1016/j.ejphar.2015.12.027", "26698392"]}, {"Citation": "Ahn M. Y., Hwang J. S., Lee S. B, et al. Curcumin longa extract-loaded nanoemulsion improves the survival of endotoxemic mice by inhibiting nitric oxide-dependent HMGB1 release. PeerJ. 2017;5:p. e3808. doi: 10.7717/peerj.3808.", "ArticleIdList": ["10.7717/peerj.3808", "PMC5600948", "28929026"]}, {"Citation": "Siddiqui A. M., Cui X., Wu R., et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-\u03b3. Critical Care Medicine. 2006;34(7):1874\u20131882. doi: 10.1097/01.ccm.0000221921.71300.bf.", "ArticleIdList": ["10.1097/01.ccm.0000221921.71300.bf", "16715036"]}, {"Citation": "Vachharajani V., Wang S. W., Mishra N., El Gazzar M., Yoza B., McCall C. Curcumin modulates leukocyte and platelet adhesion in murine sepsis. Microcirculation. 2010;17(6):407\u2013416.", "ArticleIdList": ["PMC2919812", "20690979"]}, {"Citation": "Kumari A., Tyagi N., Dash D., Singh R. Intranasal curcumin ameliorates lipopolysaccharide-induced acute lung injury in mice. Inflammation. 2015;38(3):1103\u20131112. doi: 10.1007/s10753-014-0076-y.", "ArticleIdList": ["10.1007/s10753-014-0076-y", "25526714"]}, {"Citation": "Kim J., Jeong S.-W., Quan H., Jeong C.-W., Choi J.-I., Bae H.-B. Effect of curcumin (Curcuma longa extract) on LPS-induced acute lung injury is mediated by the activation of AMPK. Journal of Anesthesia. 2016;30(1):100\u2013108. doi: 10.1007/s00540-015-2073-1.", "ArticleIdList": ["10.1007/s00540-015-2073-1", "26335543"]}, {"Citation": "Zhong W., Qian K., Xiong J., Ma K., Wang A., Zou Y. Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-\u03baB related signaling. Biomedicine & Pharmacotherapy. 2016;83:302\u2013313. doi: 10.1016/j.biopha.2016.06.036.", "ArticleIdList": ["10.1016/j.biopha.2016.06.036", "27393927"]}, {"Citation": "Kumari A., Dash D., Singh R. Curcumin inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway inflammation through modulation of sequential release of inflammatory mediators (TNF-\u03b1 and TGF-\u03b21) in murine model. Inflammopharmacology. 2017;25(3):329\u2013341. doi: 10.1007/s10787-017-0334-3.", "ArticleIdList": ["10.1007/s10787-017-0334-3", "28289922"]}, {"Citation": "Yang C., Wu K., Li S.-H., You Q. Protective effect of curcumin against cardiac dysfunction in sepsis rats. Pharmaceutical Biology. 2013;51(4):482\u2013487. doi: 10.3109/13880209.2012.742116.", "ArticleIdList": ["10.3109/13880209.2012.742116", "23336318"]}, {"Citation": "Sompamit K., Kukongviriyapan U., Nakmareong S., Pannangpetch P., Kukongviriyapan V. Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharide-induced endotoxaemia in mice. European Journal of Pharmacology. 2009;616(1\u20133):192\u2013199. doi: 10.1016/j.ejphar.2009.06.014.", "ArticleIdList": ["10.1016/j.ejphar.2009.06.014", "19540224"]}, {"Citation": "Anuthakoengkun A., Itharat A. Inhibitory effect on nitric oxide production and free radical scavenging activity of Thai medicinal plants in osteoarthritic knee treatment. Journal of the Medical Association of Thailand. 2014;97:S116\u2013S124.", "ArticleIdList": ["25518303"]}, {"Citation": "Liang Y. D., Bai W. J., Li C. G, et al. Piperine suppresses pyroptosis and interleukin-1\u03b2 release upon ATP triggering and bacterial infection. Frontiers in Pharmacology. 2016;7:p. 390. doi: 10.3389/fphar.2016.00390.", "ArticleIdList": ["10.3389/fphar.2016.00390", "PMC5071324", "27812336"]}, {"Citation": "Ku S.-K., Lee I.-C., Kim J. A., Bae J.-S. Anti-septic effects of pellitorine in HMGB1-induced inflammatory responses in vitro and in vivo. Inflammation. 2014;37(2):338\u2013348. doi: 10.1007/s10753-013-9745-5.", "ArticleIdList": ["10.1007/s10753-013-9745-5", "24077682"]}, {"Citation": "Bae G. S., Kim M. S., Jung W. S, et al. Inhibition of lipopolysaccharide-induced inflammatory responses by piperine. European Journal of Pharmacology. 2010;642(1\u20133):154\u2013162. doi: 10.1016/j.ejphar.2010.05.026.", "ArticleIdList": ["10.1016/j.ejphar.2010.05.026", "20621590"]}, {"Citation": "Lu Y., Liu J., Li H., Gu L. Piperine ameliorates lipopolysaccharide-induced acute lung injury via modulating NF-\u03baB signaling pathways. Inflammation. 2016;39(1):303\u2013308. doi: 10.1007/s10753-015-0250-x.", "ArticleIdList": ["10.1007/s10753-015-0250-x", "26410851"]}, {"Citation": "Kim S. S., Oh O.-J., Min H.-Y., et al. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sciences. 2003;73(3):337\u2013348. doi: 10.1016/s0024-3205(03)00288-1.", "ArticleIdList": ["10.1016/s0024-3205(03)00288-1", "12757841"]}, {"Citation": "Bachiega T. F., de Sousa J. P. B., Bastos J. K., Sforcin J. M. Clove and eugenol in noncytotoxic concentrations exert immunomodulatory/anti-inflammatory action on cytokine production by murine macrophages. Journal of Pharmacy and Pharmacology. 2012;64(4):610\u2013616. doi: 10.1111/j.2042-7158.2011.01440.x.", "ArticleIdList": ["10.1111/j.2042-7158.2011.01440.x", "22420667"]}, {"Citation": "Lee H.-H., Shin J.-S., Lee W.-S., Ryu B., Jang D. S., Lee K.-T. Biflorin, isolated from the flower buds of Syzygium aromaticum L., suppresses LPS-induced inflammatory mediators via STAT1 inactivation in macrophages and protects mice from endotoxin shock. Journal of Natural Products. 2016;79(4):711\u2013720. doi: 10.1021/acs.jnatprod.5b00609.", "ArticleIdList": ["10.1021/acs.jnatprod.5b00609", "26977531"]}, {"Citation": "Chniguir A., Zioud F., Marzaioli V., El-Benna J., Bachoual R. Syzygium aromaticum aqueous extract inhibits human neutrophils myeloperoxidase and protects mice from LPS-induced lung inflammation. Pharmaceutical Biology. 2019;57(1):55\u201363. doi: 10.1080/13880209.2018.1557697.", "ArticleIdList": ["10.1080/13880209.2018.1557697", "PMC6366422", "30707845"]}, {"Citation": "Lii C.-K., Chen H.-W., Yun W.-T., Liu K.-L. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW 264.7 macrophages. Journal of Ethnopharmacology. 2009;122(2):227\u2013233. doi: 10.1016/j.jep.2009.01.028.", "ArticleIdList": ["10.1016/j.jep.2009.01.028", "19330915"]}, {"Citation": "Yang W. S., Yang E., Kim M.-J., et al. Momordica charantia inhibits inflammatory responses in murine macrophages via suppression of TAK1. The American Journal of Chinese Medicine. 2018;46(02):435\u2013452. doi: 10.1142/s0192415x18500222.", "ArticleIdList": ["10.1142/s0192415x18500222", "29463104"]}, {"Citation": "Huang C.-j., Wu M.-C. Differential effects of foods traditionally regarded as \u2018heating\u2019 and \u2018cooling\u2019 on prostaglandin E2 production by a macrophage cell line. Journal of Biomedical Science. 2002;9(6):596\u2013606. doi: 10.1159/000067288.", "ArticleIdList": ["10.1159/000067288", "12432225"]}, {"Citation": "Pham T. M. H., Ngo D.-H., Ngo D.-N., Vo T. S. Investigation of biological activities of wild bitter melon (Momordica charantia Linn. var. abbreviata ser.) Biomolecules. 2019;9(6):p. 211. doi: 10.3390/biom9060211.", "ArticleIdList": ["10.3390/biom9060211", "PMC6627102", "31151277"]}, {"Citation": "Ciou S. Y., Hsu C. C., Kuo Y. H., Chao C. Y. Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis. BioMedicine. 2014;4(3) doi: 10.7603/s40681-014-0017-y.", "ArticleIdList": ["10.7603/s40681-014-0017-y", "PMC4264976", "25520930"]}, {"Citation": "Hafiz Z. Z., Amin M. A. M., Johari James R. M., Teh L. K., Salleh M. Z., Adenan M. I. Inhibitory effects of raw-extract Centella asiatica (RECA) on acetylcholinesterase, inflammations, and oxidative stress activities via in vitro and in vivo. Molecules. 2020;25(4):p. 892. doi: 10.3390/molecules25040892.", "ArticleIdList": ["10.3390/molecules25040892", "PMC7070982", "32079355"]}, {"Citation": "Yuyun X., Xi C., Qing Y., Lin X., Ke R., Bingwei S. Asiatic acid attenuates lipopolysaccharide-induced injury by suppressing activation of the Notch signaling pathway. Oncotarget. 2018;9(19):p. 15036. doi: 10.18632/oncotarget.24542.", "ArticleIdList": ["10.18632/oncotarget.24542", "PMC5871095", "29599924"]}, {"Citation": "Zhang L.-N., Zheng J.-J., Zhang L., et al. Protective effects of asiaticoside on septic lung injury in mice. Experimental and Toxicologic Pathology. 2011;63(6):519\u2013525. doi: 10.1016/j.etp.2010.04.002.", "ArticleIdList": ["10.1016/j.etp.2010.04.002", "20471230"]}, {"Citation": "Wan J., Yu L., Zhang X., et al. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-\u03baB signaling pathway. International Immunopharmacology. 2015;26(1):181\u2013187. doi: 10.1016/j.intimp.2015.03.022.", "ArticleIdList": ["10.1016/j.intimp.2015.03.022", "25835778"]}, {"Citation": "Zhang L., Li H.-Z., Gong X., et al. Protective effects of Asiaticoside on acute liver injury induced by lipopolysaccharide/D-galactosamine in mice. Phytomedicine. 2010;17(10):811\u2013819. doi: 10.1016/j.phymed.2010.01.008.", "ArticleIdList": ["10.1016/j.phymed.2010.01.008", "20171071"]}, {"Citation": "Wan J., Gong X., Jiang R., Zhang Z., Zhang L. Antipyretic and anti-inflammatory effects of asiaticoside in lipopolysaccharide-treated rat through up-regulation of heme oxygenase-1. Phytotherapy Research. 2013;27(8):1136\u20131142. doi: 10.1002/ptr.4838.", "ArticleIdList": ["10.1002/ptr.4838", "22972613"]}, {"Citation": "Li Z., Xiao X., Yang M. Asiatic acid inhibits lipopolysaccharide-induced acute lung injury in mice. Inflammation. 2016;39(5):1642\u20131648. doi: 10.1007/s10753-016-0398-z.", "ArticleIdList": ["10.1007/s10753-016-0398-z", "27395046"]}, {"Citation": "Cao W., Li X.-Q., Zhang X.-N., et al. Madecassoside suppresses LPS-induced TNF-\u03b1 production in cardiomyocytes through inhibition of ERK, p38, and NF-\u03baB activity. International Immunopharmacology. 2010;10(7):723\u2013729. doi: 10.1016/j.intimp.2010.03.015.", "ArticleIdList": ["10.1016/j.intimp.2010.03.015", "20381648"]}, {"Citation": "Wang W., Wu L., Li Q., et al. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-\u03baB and activating Nrf2/HO-1 signaling. Biomedicine & Pharmacotherapy. 2018;103:1137\u20131145. doi: 10.1016/j.biopha.2018.04.162.", "ArticleIdList": ["10.1016/j.biopha.2018.04.162", "29715757"]}, {"Citation": "Jiang C., Mayeux P. R., Nguyen T., et al. The endothelium in sepsis. Shock. 2016;45(3):p. 259. doi: 10.1097/shk.0000000000000473.", "ArticleIdList": ["10.1097/shk.0000000000000473", "PMC5281063", "26871664"]}, {"Citation": "Okhuarobo A., Ehizogie Falodun J., Erharuyi O., Imieje V., Falodun A., Langer P. Harnessing the medicinal properties of Andrographis paniculata for diseases and beyond: a review of its phytochemistry and pharmacology. Asian Pacific Journal of Tropical Disease. 2014;4(3):p. 213. doi: 10.1016/s2222-1808(14)60509-0.", "ArticleIdList": ["10.1016/s2222-1808(14)60509-0"]}, {"Citation": "Mishra U., Mishra A., Kumari R., Murthy P., Naik B. Antibacterial activity of ethanol extract ofAndrographis paniculata. Indian Journal of Pharmaceutical Sciences. 2009;71(4):p. 436. doi: 10.4103/0250-474x.57294.", "ArticleIdList": ["10.4103/0250-474x.57294", "PMC2865817", "20502551"]}, {"Citation": "Sheeja K., Shihab P. K., Kuttan G. Antioxidant and anti-inflammatory activities of the PlantAndrographis PaniculataNees. Immunopharmacology and Immunotoxicology. 2006;28(1):129\u2013140. doi: 10.1080/08923970600626007.", "ArticleIdList": ["10.1080/08923970600626007", "16684672"]}, {"Citation": "Nugroho A., Warditiani N., Pramono S., Andrie M., Siswanto E., Lukitaningsih E. Antidiabetic and antihiperlipidemic effect of Andrographis paniculata (Burm. f.) Nees and andrographolide in high-fructose-fat-fed rats. Indian Journal of Pharmacology. 2012;44(3):p. 377. doi: 10.4103/0253-7613.96343.", "ArticleIdList": ["10.4103/0253-7613.96343", "PMC3371463", "22701250"]}, {"Citation": "Chao W.-W., Kuo Y.-H., Lin B.-F. Anti-inflammatory activity of new compounds from Andrographis paniculata by NF-\u03baB transactivation inhibition. Journal of Agricultural and Food Chemistry. 2010;58(4):2505\u20132512. doi: 10.1021/jf903629j.", "ArticleIdList": ["10.1021/jf903629j", "20085279"]}, {"Citation": "Liu J., Wang Z. T., Ji L. L., Ge B. X. Inhibitory effects of neoandrographolide on nitric oxide and prostaglandin E 2 production in LPS-stimulated murine macrophage. Molecular and Cellular Biochemistry. 2007;298(1-2):49\u201357. doi: 10.1007/s11010-006-9349-6.", "ArticleIdList": ["10.1007/s11010-006-9349-6", "17109078"]}, {"Citation": "Liu J., Wang Z.-T., Ji L.-L. In vivo and in vitro anti-inflammatory activities of neoandrographolide. The American Journal of Chinese Medicine. 2007;35(2):317\u2013328. doi: 10.1142/s0192415x07004849.", "ArticleIdList": ["10.1142/s0192415x07004849", "17436371"]}, {"Citation": "Chandrasekaran C. V., Thiyagarajan P., Deepak H. B., Agarwal A. In vitro modulation of LPS/calcimycin induced inflammatory and allergic mediators by pure compounds of Andrographis paniculata (King of bitters) extract. International Immunopharmacology. 2011;11(1):79\u201384. doi: 10.1016/j.intimp.2010.10.009.", "ArticleIdList": ["10.1016/j.intimp.2010.10.009", "21034865"]}, {"Citation": "Liu J., Wang Z.-T., Ge B.-X. Andrograpanin, isolated from Andrographis paniculata, exhibits anti-inflammatory property in lipopolysaccharide-induced macrophage cells through down-regulating the p38 MAPKs signaling pathways. International Immunopharmacology. 2008;8(7):951\u2013958. doi: 10.1016/j.intimp.2007.12.014.", "ArticleIdList": ["10.1016/j.intimp.2007.12.014", "18486905"]}, {"Citation": "Stoilova I., Krastanov A., Stoyanova A., Denev P., Gargova S. Antioxidant activity of a ginger extract (Zingiber officinale) Food Chemistry. 2007;102(3):764\u2013770. doi: 10.1016/j.foodchem.2006.06.023.", "ArticleIdList": ["10.1016/j.foodchem.2006.06.023"]}, {"Citation": "Penna S. C., Medeiros M. V., Aimbire F. S. C., Faria-Neto H. C. C., Serti\u00e9 J. A. A., Lopes-Martins R. A. B. Anti-inflammatory effect of the hydralcoholic extract of Zingiber officinale rhizomes on rat paw and skin edema. Phytomedicine. 2003;10(5):381\u2013385. doi: 10.1078/0944-7113-00271.", "ArticleIdList": ["10.1078/0944-7113-00271", "12834002"]}, {"Citation": "Habib S. H., Makpol S., Hamid N. A., Das S., Ngah W. Z., Yusof Y. A. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics. 2008;63(6):807\u2013813. doi: 10.1590/s1807-59322008000600017.", "ArticleIdList": ["10.1590/s1807-59322008000600017", "PMC2664283", "19061005"]}, {"Citation": "Amran A. Z., Jantan I., Dianita R., Buang F. Protective effects of the standardized extract of Zingiber officinale on myocardium against isoproterenol-induced biochemical and histopathological alterations in rats. Pharmaceutical Biology. 2015;53(12):1795\u20131802. doi: 10.3109/13880209.2015.1008147.", "ArticleIdList": ["10.3109/13880209.2015.1008147", "25868620"]}, {"Citation": "Mukherjee D., Ahmad R. COX-2/iNOS regulation during experimental hepatic injury and its mitigation by cloudy apple juice. International Journal of Biological Macromolecules. 2019;140:1006\u20131017. doi: 10.1016/j.ijbiomac.2019.08.180.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.08.180", "31445146"]}, {"Citation": "Koh E., Kim H., Kim S., et al. Modulation of macrophage functions by compounds isolated from Zingiber officinale. Planta Medica. 2009;75(02):148\u2013151. doi: 10.1055/s-0028-1088347.", "ArticleIdList": ["10.1055/s-0028-1088347", "19031369"]}, {"Citation": "Pan M.-H., Hsieh M.-C., Hsu P.-C., et al. 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Molecular Nutrition & Food Research. 2008c;52(12):1467\u20131477. doi: 10.1002/mnfr.200700515.", "ArticleIdList": ["10.1002/mnfr.200700515", "18683823"]}, {"Citation": "Dugasani S., Pichika M. R., Nadarajah V. D., Balijepalli M. K., Tandra S., Korlakunta J. N. Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. Journal of Ethnopharmacology. 2010;127(2):515\u2013520. doi: 10.1016/j.jep.2009.10.004.", "ArticleIdList": ["10.1016/j.jep.2009.10.004", "19833188"]}, {"Citation": "Hong S. S., Oh J. S. Phenylpropanoid ester from Zingiber officinale and their inhibitory effects on the production of nitric oxide. Archives of Pharmacal Research. 2012;35(2):315\u2013320. doi: 10.1007/s12272-012-0211-y.", "ArticleIdList": ["10.1007/s12272-012-0211-y", "22370785"]}, {"Citation": "Li F., Nitteranon V., Tang X., et al. In vitro antioxidant and anti-inflammatory activities of 1-dehydro-[6]-gingerdione, 6-shogaol, 6-dehydroshogaol and hexahydrocurcumin. Food Chemistry. 2012;135(2):332\u2013337. doi: 10.1016/j.foodchem.2012.04.145.", "ArticleIdList": ["10.1016/j.foodchem.2012.04.145", "22868095"]}, {"Citation": "Han Y. a., Song C. w., Koh W. s., et al. Anti-inflammatory effects of the Zingiber officinale roscoe constituent 12-dehydrogingerdione in lipopolysaccharide-stimulated raw 264.7 cells. Phytotherapy Research. 2013;27(8):1200\u20131205. doi: 10.1002/ptr.4847.", "ArticleIdList": ["10.1002/ptr.4847", "23027684"]}, {"Citation": "Salama S. M., Abdulla M. A., AlRashdi A. S., Ismail S., Alkiyumi S. S., Golbabapour S. Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats. BMC Complementary and Alternative Medicine. 2013;13(1):p. 56. doi: 10.1186/1472-6882-13-56.", "ArticleIdList": ["10.1186/1472-6882-13-56", "PMC3605171", "23496995"]}, {"Citation": "Chandrasekaran C., Sundarajan K., Edwin J., Gururaja G., Mundkinajeddu D. Immune-stimulatory and anti-inflammatory activities of Curcuma longa extract and its polysaccharide fraction. Pharmacognosy Research. 2013;5(2):p. 71. doi: 10.4103/0974-8490.110527.", "ArticleIdList": ["10.4103/0974-8490.110527", "PMC3685767", "23798880"]}, {"Citation": "Agarwal I. A., Wan Ahmad W. A. N., Ramli N. S., Ghafar N. A. Antimicrobial and antioxidant property of Curcuma longa Linn. International Journal of Basic & Clinical Pharmacology. 2019;8(11):p. 2383. doi: 10.18203/2319-2003.ijbcp20194772.", "ArticleIdList": ["10.18203/2319-2003.ijbcp20194772"]}, {"Citation": "Ichsyani M., Ridhanya A., Risanti M, et al. Antiviral effects of Curcuma longa L. against dengue virus in vitro and in vivo. IOP Conference Series: Earth and Environmental Science. 2017;101(1) doi: 10.1088/1755-1315/101/1/012005.", "ArticleIdList": ["10.1088/1755-1315/101/1/012005"]}, {"Citation": "Chen C., Long L., Zhang F, et al. Antifungal activity, main active components and mechanism of Curcuma longa extract against Fusarium graminearum. P.oS One. 2018;13(3) doi: 10.1371/journal.pone.0194284.", "ArticleIdList": ["10.1371/journal.pone.0194284", "PMC5854386", "29543859"]}, {"Citation": "Kuroda M., Mimaki Y., Nishiyama T., et al. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biological & Pharmaceutical Bulletin. 2005;28(5):937\u2013939. doi: 10.1248/bpb.28.937.", "ArticleIdList": ["10.1248/bpb.28.937", "15863912"]}, {"Citation": "Corrigan M., Wilson S. S., Hampton J. Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings. American Journal of Health-System Pharmacy. 2015;72(18):1544\u20131554. doi: 10.2146/ajhp140630.", "ArticleIdList": ["10.2146/ajhp140630", "26346210"]}, {"Citation": "Okuda-Hanafusa C., Uchio R., Fuwa A., et al. Turmeronol A and turmeronol B from Curcuma longa prevent inflammatory mediator production by lipopolysaccharide-stimulated RAW264.7 macrophages, partially via reduced NF-\u03baB signaling. Food & Function. 2019;10(9):5779\u20135788. doi: 10.1039/c9fo00336c.", "ArticleIdList": ["10.1039/c9fo00336c", "31454011"]}, {"Citation": "Kawasaki K., Okuda-Hanafusa C., Aoyagi M., et al. Inhibitory effect of the compounds from the water extract of Curcuma longa on the production of PGE2 and NO in a macrophage cell line stimulated by LPS. Bioscience, Biotechnology, and Biochemistry. 2018;82(12):2109\u20132117. doi: 10.1080/09168451.2018.1511366.", "ArticleIdList": ["10.1080/09168451.2018.1511366", "30146952"]}, {"Citation": "Tham C. L., Lam K. W., Rajajendram R., et al. The effects of a synthetic curcuminoid analogue, 2, 6-bis-(4-hydroxyl-3-methoxybenzylidine) cyclohexanone on proinflammatory signaling pathways and CLP-induced lethal sepsis in mice. European Journal of Pharmacology. 2011;652(1\u20133):136\u2013144. doi: 10.1016/j.ejphar.2010.10.092.", "ArticleIdList": ["10.1016/j.ejphar.2010.10.092", "21114991"]}, {"Citation": "Wang Y., Shan X., Dai Y., et al. Curcumin analog L48H37 prevents lipopolysaccharide-induced TLR4 signaling pathway activation and sepsis via targeting MD2. Journal of Pharmacology and Experimental Therapeutics. 2015;353(3):539\u2013550. doi: 10.1124/jpet.115.222570.", "ArticleIdList": ["10.1124/jpet.115.222570", "25862641"]}, {"Citation": "Zhao C., Zhang Y., Zou P., et al. Synthesis and biological evaluation of a novel class of curcumin analogs as anti-inflammatory agents for prevention and treatment of sepsis in mouse model. Drug Design, Development and Therapy. 2015;9:p. 1663. doi: 10.2147/dddt.s75862.", "ArticleIdList": ["10.2147/dddt.s75862", "PMC4370917", "25834403"]}, {"Citation": "Qian J., Chen X., Shu S., et al. Design and synthesis novel di-carbonyl analogs of curcumin (DACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) European Journal of Medicinal Chemistry. 2019;167:414\u2013425. doi: 10.1016/j.ejmech.2019.02.042.", "ArticleIdList": ["10.1016/j.ejmech.2019.02.042", "30780088"]}, {"Citation": "Aluwi M. F., Rullah K., Yamin B. M., et al. Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines. Bioorganic & Medicinal Chemistry Letters. 2016;26(10):2531\u20132538.", "ArticleIdList": ["27040659"]}, {"Citation": "Zhu H., Xu T., Qiu C., et al. Synthesis and optimization of novel allylated mono-carbonyl analogs of curcumin (MACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) in rats. European Journal of Medicinal Chemistry. 2016;121:181\u2013193. doi: 10.1016/j.ejmech.2016.05.041.", "ArticleIdList": ["10.1016/j.ejmech.2016.05.041", "27240273"]}, {"Citation": "Ahmad F., Khan G. M., Abbasi B. H., Farooq S., Ali M., Khan M. A. Study of aging and hepatoprotective activity of Vitis vinifera L. Seeds in albino rats. Asian Pacific Journal of Tropical Biomedicine. 2012;2(3):S1770\u2013S1774. doi: 10.1016/s2221-1691(12)60524-3.", "ArticleIdList": ["10.1016/s2221-1691(12)60524-3"]}, {"Citation": "Akthar M. S., Birhanu G., Demisse S. Antimicrobial activity of Piper nigrum L. and Cassia didymobotyra L. leaf extract on selected food borne pathogens. Asian Pacific Journal of Tropical Disease. 2014;4:S911\u2013S919. doi: 10.1016/s2222-1808(14)60757-x.", "ArticleIdList": ["10.1016/s2222-1808(14)60757-x"]}, {"Citation": "G\u00fcl\u00e7in \u0130. The antioxidant and radical scavenging activities of black pepper (Piper nigrum) seeds. International Journal of Food Sciences and Nutrition. 2005;56(7):491\u2013499. doi: 10.1080/09637480500450248.", "ArticleIdList": ["10.1080/09637480500450248", "16503560"]}, {"Citation": "Deng Y., Sriwiriyajan S., Tedasen A., Hiransai P., Graidist P. Anti-cancer effects of Piper nigrum via inducing multiple molecular signaling in vivo and in vitro. Journal of Ethnopharmacology. 2016;188:87\u201395. doi: 10.1016/j.jep.2016.04.047.", "ArticleIdList": ["10.1016/j.jep.2016.04.047", "27155135"]}, {"Citation": "Nirwane A. M., Bapat A. R. Effect of methanolic extract of Piper nigrum fruits in ethanol-CCl4 induced hepatotoxicity in Wistar rats. Der Pharmacia Lettre. 2012;4(3):795\u2013802."}, {"Citation": "Tasleem F., Azhar I., Ali S. N., Perveen S., Mahmood Z. A. Analgesic and anti-inflammatory activities of Piper nigrum L. Asian Pacific Journal of Tropical Medicine. 2014;7:S461\u2013S468. doi: 10.1016/s1995-7645(14)60275-3.", "ArticleIdList": ["10.1016/s1995-7645(14)60275-3", "25312168"]}, {"Citation": "Ngo Q. M. T., Tran P. T., Tran M. H., et al. Alkaloids fromPiper nigrumExhibit antiinflammatory activity via activating the Nrf2/HO\u00ad1 pathway. Phytotherapy Research. 2017;31(4):663\u2013670. doi: 10.1002/ptr.5780.", "ArticleIdList": ["10.1002/ptr.5780", "28185326"]}, {"Citation": "Pei H., Xue L., Tang M., et al. Alkaloids from black pepper (piper nigrum L.) exhibit anti-inflammatory activity in murine macrophages by inhibiting activation of NF-\u03baB pathway. Journal of Agricultural and Food Chemistry. 2020;68(8):2406\u20132417. doi: 10.1021/acs.jafc.9b07754.", "ArticleIdList": ["10.1021/acs.jafc.9b07754", "32031370"]}, {"Citation": "Ye D. F., de Souza C. R. F., Oliveira W. P. Clove (Syzygium aromaticum): a precious spice. Asian Pacific Journal of Tropical Biomedicine. 2014;4(2):90\u201396. doi: 10.1016/s2221-1691(14)60215-x.", "ArticleIdList": ["10.1016/s2221-1691(14)60215-x", "PMC3819475", "25182278"]}, {"Citation": "Nana W. L., Eke P., Fokom R, et al. Antimicrobial activity of Syzygium aromaticum and Zanthoxylum xanthoxyloides essential oils against Phytophthora megakarya. Journal of Phytopathology. 2015;163(7-8):632\u2013641. doi: 10.1111/jph.12363.", "ArticleIdList": ["10.1111/jph.12363"]}, {"Citation": "Tanko Y., Mohammed A., Okasha M. A., Umah A., Magaji R. Anti-nociceptive and anti-inflammatory activities of ethanol extract of Syzygium aromaticum flower bud in wistar rats and mice. African Journal of Traditional, Complementary and Alternative Medicines. 2008;5(2):209\u2013212. doi: 10.4314/ajtcam.v5i2.31275.", "ArticleIdList": ["10.4314/ajtcam.v5i2.31275", "PMC2816534", "20161939"]}, {"Citation": "Lee K.-G., Shibamoto T. Antioxidant property of aroma extract isolated from clove buds [Syzygium aromaticum (L.) Merr. et Perry] Food Chemistry. 2001;74(4):443\u2013448. doi: 10.1016/s0308-8146(01)00161-3.", "ArticleIdList": ["10.1016/s0308-8146(01)00161-3"]}, {"Citation": "Agarwal A. Antibacterial activity of some plants against drug resistant neonatal sepsis causing bacteria. November 2019.   https://storage.googleapis.com/journal-uploads/wjpps/article_issue/1444051044.pdf."}, {"Citation": "Gill N. S., Rani P., Arora R., Dhawan V., Bali M. Evaluation of antioxidant, antiinflammatory and antiulcer potential of Momordica charantia methanolic seed extract. Research Journal of Phytochemistry. 2012;6(4):96\u2013104. doi: 10.3923/rjphyto.2012.96.104.", "ArticleIdList": ["10.3923/rjphyto.2012.96.104"]}, {"Citation": "Thiagarajan S., Arapoc D. J., Husna Shafie N., et al. Momordica charantia (Indian and Chinese bitter melon) extracts inducing apoptosis in human lung cancer cell line A549 via ROS-mediated mitochodria injury. Evidence-Based Complementary and Alternative Medicine. 2019;2019:9. doi: 10.1155/2019/2821597.2821597", "ArticleIdList": ["10.1155/2019/2821597", "PMC6431397", "30956678"]}, {"Citation": "Mwambete K. D. The in vitro antimicrobial activity of fruit and leaf crude extracts of Momordica charantia: a Tanzania medicinal plant. African Health Sciences. 2009;9(1):34\u201339.", "ArticleIdList": ["PMC2932517", "20842240"]}, {"Citation": "Fachinan R., Yessoufou A., Nekoua M. P., Moutairou K. Effectiveness of antihyperglycemic effect of Momordica charantia: implication of t-cell cytokines. Evidence-Based Complementary and Alternative Medicine. 2017;2017:8. doi: 10.1155/2017/3707046.3707046", "ArticleIdList": ["10.1155/2017/3707046", "PMC5727634", "29317893"]}, {"Citation": "Joseph B., Jini D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pacific Journal of Tropical Disease. 2013;3(2):93\u2013102. doi: 10.1016/s2222-1808(13)60052-3.", "ArticleIdList": ["10.1016/s2222-1808(13)60052-3"]}, {"Citation": "Shivanagoudra S. R., Perera W. H., Perez J. L., et al. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L. Bioorganic & Medicinal Chemistry. 2019;27(14):3097\u20133109. doi: 10.1016/j.bmc.2019.05.035.", "ArticleIdList": ["10.1016/j.bmc.2019.05.035", "31196754"]}, {"Citation": "Shivanagoudra S. R., Perera W. H., Perez J. L., et al. Cucurbitane-type compounds from Momordica charantia: isolation, in vitro antidiabetic, anti-inflammatory activities and in silico modeling approaches. Bioorganic Chemistry. 2019;87:31\u201342. doi: 10.1016/j.bioorg.2019.02.040.", "ArticleIdList": ["10.1016/j.bioorg.2019.02.040", "30856374"]}, {"Citation": "Hashim P., Sidek H., Helan M., Sabery A., Palanisamy U. D., Ilham M. Triterpene composition and bioactivities of Centella asiatica. Molecules. 2011 Feb;16(2):1310\u20131322. doi: 10.3390/molecules16021310.", "ArticleIdList": ["10.3390/molecules16021310", "PMC6259745", "21278681"]}, {"Citation": "Alfarra H. Y., Omar M. N. Centella asiatica: from folk remedy to the medicinal biotechnology-a state revision. International Journal of Biosciences. 2013;3(6):49\u201367."}, {"Citation": "Jamil S. S., Nizami Q., Salam M. Centella asiatica (Linn.) Urban\u2014a review. Indian Journal of Natural Products and Resources. 2007;6:158\u2013170."}, {"Citation": "Won J.-H., Shin J.-S., Park H.-J., et al. Anti-inflammatory effects of madecassic acid via the suppression of NF-\u03baB pathway in LPS-induced RAW 264.7 macrophage cells. Planta Medica. 2010;76(03):251\u2013257. doi: 10.1055/s-0029-1186142.", "ArticleIdList": ["10.1055/s-0029-1186142", "19774506"]}, {"Citation": "Nhiem N. X., Tai B. H., Quang T. H., et al. A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-\u03b1 in activated RAW 264.7 cells. Bioorganic & Medicinal Chemistry Letters. 2011;21(6):1777\u20131781. doi: 10.1016/j.bmcl.2011.01.066.", "ArticleIdList": ["10.1016/j.bmcl.2011.01.066", "21353543"]}, {"Citation": "Uppu D. S. S. M., Ghosh C., Haldar J. Surviving sepsis in the era of antibiotic resistance: are there any alternative approaches to antibiotic therapy? Microbial Pathogenesis. 2015;80:7\u201313. doi: 10.1016/j.micpath.2015.02.001.", "ArticleIdList": ["10.1016/j.micpath.2015.02.001", "25677832"]}, {"Citation": "Chen H. C., Chen W. C., Lin K. H., et al. Simultaneous use of traditional Chinese medicine (Si-Ni-Tang) to treat septic shock patients: study protocol for a randomized controlled trial. Trials. 2011;12(1):p. 199. doi: 10.1186/1745-6215-12-199.", "ArticleIdList": ["10.1186/1745-6215-12-199", "PMC3178491", "21864392"]}, {"Citation": "Ko\u0161t\u2019\u00e1lov\u00e1 D., Bez\u00e1kov\u00e1 L., Ra\u010dkov\u00e1c L., Mo\u0161ovsk\u00e1 S., \u0160turd\u00edk E. Therapeutic potential of curcumin in medicinal chemistry. Acta Chimica Slovaca. 2013;6(1):89\u201399."}, {"Citation": "He H., Guo W. W., Chen X. Q., Zhao H. Y., Wu X. Comparative metabolism of three amide alkaloids from Piper longum in five different species of liver microsomes. China Journal of Chinese Materia Medica. 2016;41(16):3084\u20133089.", "ArticleIdList": ["28920353"]}, {"Citation": "Vasconcellos M. C., Montenegro R. C., Milit\u00e3o G. C., et al. Bioactivity of biflorin, a typical o-naphthoquinone isolated from Capraria biflora L. Zeitschrift f\u00fcr Naturforschung C. 2005;60(5-6):394\u2013398. doi: 10.1515/znc-2005-5-605.", "ArticleIdList": ["10.1515/znc-2005-5-605", "16042338"]}]}], "History": [{"Year": "2020", "Month": "5", "Day": "28"}, {"Year": "2020", "Month": "9", "Day": "28"}, {"Year": "2020", "Month": "10", "Day": "1"}, {"Year": "2020", "Month": "11", "Day": "16", "Hour": "8", "Minute": "49"}, {"Year": "2020", "Month": "11", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "17", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "10", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["33193799", "PMC7641701", "10.1155/2020/8257817"]}}]}